You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC / CE

Concepts to Practice: The Evolving Landscape in Topical Therapies for Plaque Psoriasis

  • Authors: April Armstrong, MD, MPH; Melinda Gooderham, MD, MSc, FRCPC; Melodie Young, MSN, A/GNP-C
  • CME / ABIM MOC / CE Released: 11/30/2022
  • Valid for credit through: 11/30/2023
Start Activity

  • Credits Available

    Physicians - maximum of 0.75 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 0.75 ABIM MOC points

    Nurses - 0.75 ANCC Contact Hour(s) (0.5 contact hours are in the area of pharmacology)

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for dermatologists, primary care physicians, nurses, nurse practitioners, physician assistants, and other clinicians who treat patients with psoriasis.

The goal of this activity is for learners to be better able to optimize treatment of patients with psoriasis.

Upon completion of this activity, participants will:

  • Have greater competence related to
    • Incorporating evidence-based topical treatments into comprehensive management plans for patients with plaque psoriasis
    • Managing psoriasis in patients with skin of color
    • Tailoring topical treatment selection based on patient characteristics and goals
  • Demonstrate greater confidence in their ability to
    • Employ shared decision-making to provide patient-centered care


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.


Faculty

  • April Armstrong, MD, MPH

    Professor of Dermatology
    Associate Dean for Clinical Research
    University of Southern California
    Los Angeles, California, United States

    Disclosures

    April Armstrong, MD, MPH, has the following relevant financial relationships:
    Consultant or advisor for: AbbVie Inc.; Almirall; Arcutis Biotherapeutics, Inc.; ASLAN Pharmaceuticals Pte Ltd; Beiersdorf; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb; Dermavant Sciences, Inc.; Dermira, Inc.; EPI Health; Incyte; Janssen Pharmaceuticals, Inc.; LEO Pharma Inc.; Lilly; Modmed; Nimbus; Novartis Pharmaceuticals Corporation; Ortho Dermatologics; Parexel International Corporation; Pfizer, Inc.; Regeneron Pharmaceuticals Inc.; Sanofi-Aventis U.S. LLC; Sun Pharmaceutical Industries Ltd.; UCB, Inc.
    Research funding from: Bristol Myers Squibb; Dermavant Sciences, Inc.; Dermira, Inc.; LEO Pharma Inc.; Lilly; Pfizer, Inc.; UCB, Inc.
    Contracted researcher for: Bristol Myers Squibb; Dermavant Sciences, Inc.; Dermira, Inc.; LEO Pharma Inc.; Lilly; Pfizer, Inc.; UCB, Inc.

  • Melinda Gooderham, MD, MSc, FRCPC

    Assistant Professor
    Department of Medicine
    Queen’s University
    Kingston, Ontario, Canada
    Consultant Physician
    Peterborough Regional Health Centre
    Medical Director
    SKiN Centre for Dermatology
    Peterborough, Ontario, Canada

    Disclosures

    Melinda Gooderham, MD, MSc, FRCPC, has the following relevant financial relationships:
    Consultant or advisor for: AbbVie Inc.; Akros Pharma Inc.; Amgen, Inc.; AnaptysBio; Arcutis Biotherapeutics, Inc.; Aristea Therapeutics; Asana Bio Sciences; Aslan Pharmaceuticals; Bausch Health; Boehringer Ingelheim International GmbH; Celgene Corporation; Eli Lilly and Company; Galderma SA.; Janssen Inc.; Kyowa Kirin; LEO Pharma; Novartis Pharmaceuticals; Pfizer Inc.; Regeneron Pharmaceuticals Inc.; Sanofi Genzyme; Sun Pharmaceuticals; UCB, Inc.
    Speaker or member of speakers bureau for: AbbVie Inc.; Amgen, Inc.; Arcutis Biotherapeutics, Inc.; Aslan Pharmaceuticals; Bausch Health; Boehringer Ingelheim International GmbH; Celgene Corporation; Eli Lilly and Company; Galderma SA.; Janssen Inc.; LEO Pharma; Novartis Pharmaceuticals; Pfizer Inc.; Regeneron Pharmaceuticals Inc.; Sanofi Genzyme; Sun Pharmaceuticals; UCB, Inc.
    Research funding from: AbbVie Inc.; Akros Pharma Inc.; Amgen, Inc.; AnaptysBio; Arcutis Biotherapeutics, Inc.; Aristea Therapeutics; Aslan Pharmaceuticals; Bausch Health; Boehringer Ingelheim International GmbH; Bristol Myers Squibb Company; Celgene Corporation; Coherus Biosciences; Dermira Inc.; Eli Lilly and Company; Galderma SA.; GlaxoSmithKline; Incyte Biosciences; Janssen Inc.; Kyowa Kirin; LEO Pharma; MedImmune; Merck and Co.; MoonLake Immunotherapeutics; Nimbus Therapeutics; Novartis Pharmaceuticals; Pfizer Inc.; Regeneron Pharmaceuticals Inc.; Sanofi Genzyme; Sun Pharmaceuticals; UCB, Inc.

  • Melodie Young, MSN, A/GNP-C

    Nurse Practitioner
    Mindful Dermatology
    Dallas, Texas, United States

    Disclosures

    Melodie Young, MSN, A/GNP-C, has no relevant financial relationships.

Editor

  • Karen Badal, MD, MPH

    Senior Medical Education Director, Medscape, LLC 

    Disclosures

    Karen Badal, MD, MPH, has no relevant financial relationships.

Compliance Reviewer/Nurse Planner

  • Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP, has no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

    For Nurses

  • Awarded 0.75 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.50 contact hours are in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

Concepts to Practice: The Evolving Landscape in Topical Therapies for Plaque Psoriasis

Authors: April Armstrong, MD, MPH; Melinda Gooderham, MD, MSc, FRCPC; Melodie Young, MSN, A/GNP-CFaculty and Disclosures

CME / ABIM MOC / CE Released: 11/30/2022

Valid for credit through: 11/30/2023

processing....

A Powerpoint version of the slides from this presentation
is available for use as a professional resource from Medscape Education.

  • Print